Ocuphire Pharma Engages Investors with Presentation Update
Company Announcements

Ocuphire Pharma Engages Investors with Presentation Update

Ocuphire Pharma (OCUP) just unveiled an announcement.

Ocuphire Pharma, Inc. is set to engage with investors and other interested parties by presenting their Investor Presentation. The information shared during these sessions, while informative, is not intended for official filing or legal incorporation purposes under the Securities Exchange Act of 1934 or the Securities Act of 1933.

Learn more about OCUP stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyOcuphire Pharma to highlight APX3330 at ARVO SIG panel, ASRS meeting
GlobeNewswireOcuphire Pharma to Highlight APX3330 for Diabetic Retinopathy at Two Scientific Meetings in July
TheFlyOcuphire Pharma announces presentations on development of APX3330
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!